Here, instead of placing tumor models in cold conditions, we took advantage of CRISPRa to increase the gene expression of key BAT regulators, including UCP1, PPARGC1A and PRDM16, to engineer adipocytes to have increased glucose and fatty acid uptake and metabolism and then used them to deplete resources from cancer cells. The gene discussed is PRDM16; the disease is cancer.